{"id":"NCT01642914","sponsor":"Forest Laboratories","briefTitle":"Safety and Efficacy of Linaclotide in Patients With Chronic Constipation and Prominent Abdominal Bloating","officialTitle":"Phase 3b, Randomized, Double-Blind, Placebo-Controlled, Parallel-Group Trial of Linaclotide Administered Orally for 12 Weeks to Patients With Chronic Constipation and Prominent Abdominal Bloating at Baseline","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2012-08","primaryCompletion":"2013-05","completion":"2013-08","firstPosted":"2012-07-17","resultsPosted":"2016-04-26","lastUpdate":"2016-04-26"},"enrollment":487,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"TREATMENT"},"conditions":["Chronic Constipation","Constipation"],"interventions":[{"type":"DRUG","name":"Linaclotide 290 micrograms","otherNames":[]},{"type":"DRUG","name":"Linaclotide 145 micrograms","otherNames":[]},{"type":"DRUG","name":"Matching placebo","otherNames":[]}],"arms":[{"label":"Linaclotide 290 micrograms","type":"EXPERIMENTAL"},{"label":"Linaclotide 145 Micrograms","type":"EXPERIMENTAL"},{"label":"Placebo","type":"PLACEBO_COMPARATOR"}],"summary":"The purpose of this study is to evaluate the efficacy and safety of linaclotide compared with placebo in patients with chronic constipation (CC) and prominent abdominal bloating. This study includes an up to 3-week screening period and a 2-3 week pretreatment period. Patients who are eligible will be randomized to one of two doses of linaclotide or placebo for 12 weeks. This 12-week study will assess the effects of linaclotide on bowel movement frequency, as well as other abdominal and bowel symptoms of CC.","primaryOutcome":{"measure":"9/12 Week Complete Spontaneous Bowel Movement (CSBM) 3+1 Responder","timeFrame":"12-week treatment period","effectByArm":[{"arm":"Placebo","deltaMin":13,"sd":null},{"arm":"Linaclotide 145 Micrograms","deltaMin":24,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":"0.0264"}]},"eligibility":{"minAge":"18 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":5,"exclusionCount":4},"locations":{"siteCount":151,"countries":["United States","Canada"]},"refs":{"pmids":["33428631","26222318"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":2,"n":173},"commonTop":["Diarrhoea","Upper respiratory tract infection","Sinusitis"]}}